1. Structure and properties of pharmacologically active polymers;Ringsdorf;J. Polym. Sci. Polym. Symp.,1975
2. Phase I clinical and pharmacokinetic study of PK1 [N-(2-Hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. cancer research campaign phase I/II committee;Vasey;Clin. Cancer Res.,1999
3. A review of the latest clinical compounds to inhibit VEGF in pathological angiogenesis;Baka;Exp. Opin. Therapeut. Targets,2006
4. Pegylation, successful approach to drug delivery;Veronese;Drug Discov. Today,2005
5. Design of polymeric nanoparticles for biomedical delivery applications;Elsabahy;Chem. Soc. Rev.,2012